JPMorgan Chase & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,041,718
Closed -$309M 6342
2022
Q3
$309M Buy
2,041,718
+1,165,134
+133% +$176M 0.04% 353
2022
Q2
$128M Sell
876,584
-492,949
-36% -$71.8M 0.02% 617
2022
Q1
$162M Sell
1,369,533
-25,592
-2% -$3.03M 0.02% 600
2021
Q4
$192M Sell
1,395,125
-64,614
-4% -$8.9M 0.02% 544
2021
Q3
$203M Sell
1,459,739
-292,129
-17% -$40.6M 0.03% 537
2021
Q2
$170M Sell
1,751,868
-2,588
-0.1% -$251K 0.02% 615
2021
Q1
$120M Buy
1,754,456
+78,494
+5% +$5.37M 0.02% 714
2020
Q4
$144M Buy
1,675,962
+14,551
+0.9% +$1.25M 0.02% 603
2020
Q3
$105M Buy
1,661,411
+53,557
+3% +$3.38M 0.02% 631
2020
Q2
$118M Buy
1,607,854
+72,409
+5% +$5.29M 0.02% 574
2020
Q1
$52.3M Buy
1,535,445
+100,852
+7% +$3.43M 0.01% 736
2019
Q4
$78.1M Sell
1,434,593
-99,851
-7% -$5.44M 0.01% 696
2019
Q3
$64M Sell
1,534,444
-12,268
-0.8% -$512K 0.01% 764
2019
Q2
$65.8M Sell
1,546,712
-222,901
-13% -$9.48M 0.01% 772
2019
Q1
$91.1M Sell
1,769,613
-126,347
-7% -$6.5M 0.02% 630
2018
Q4
$70.1M Buy
1,895,960
+363,599
+24% +$13.4M 0.02% 684
2018
Q3
$57.5M Buy
1,532,361
+105,913
+7% +$3.98M 0.01% 861
2018
Q2
$56.4M Buy
1,426,448
+509,105
+55% +$20.1M 0.01% 823
2018
Q1
$23.6M Sell
917,343
-1,937
-0.2% -$49.9K 0.01% 1261
2017
Q4
$24.8M Buy
919,280
+441,027
+92% +$11.9M 0.01% 1254
2017
Q3
$18.2M Sell
478,253
-114,972
-19% -$4.37M ﹤0.01% 1393
2017
Q2
$14.8M Buy
+593,225
New +$14.8M ﹤0.01% 1474